Conformably, high levels of all CAGs, in addition to LIPT1 and CDKN2A, were significantly associated with poorer overall survival (OS) of ccRCC patients (p < 0.05) (Figure 2A). Here, CDKN2A is linked to nonpapillary renal cell carcinoma.